Exkof is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Exkof safe for pregnant women?
Pregnant women may experience moderate side effects from Exkof. It is best to stop taking Exkof immediately and inform your doctor if you notice any discomfort.
Is the use of Exkof safe during breastfeeding?
Exkof may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Exkof, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Exkof.
What is the effect of Exkof on the Kidneys?
There may be some adverse effects on kidney after taking Exkof. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Exkof on the Liver?
The liver can be affected by Exkof. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Exkof only after medical advice.
What is the effect of Exkof on the Heart?
Exkof may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Exkof should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Exkof unless your doctor advises you to do so -
Is this Exkof habit forming or addictive?
Exkof is not addictive in nature.
Interaction between Food and Exkof
Due to the absence of research, it is difficult to say how Exkof and food will interact.
Interaction between Alcohol and Exkof
Taking alcohol with Exkof can be dangerous.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
